Skip to main content

Philips extends AI-enabled CT imaging portfolio at RSNA 2021

Philips CT 5100 – Incisive – with CT Smart Workflow in use

Philips CT 5100 – Incisive – with CT Smart Workflow

November 29, 2021

  • New CT 5100 – Incisive – with CT Smart Workflow applies artificial intelligence* (AI) at every step in the CT imaging process to help customers meet financial, clinical, and operational goals
  • AI-enabled Smart Workflow is designed to streamline image acquisition and workflows, enabling more patient-centric care
  • Philips’ industry-first Tube for Life guarantee minimizes lifetime operating costs and provides reliability to help ensure efficient operation

Amsterdam, the Netherlands and Chicago, USA Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced new additions to its CT imaging portfolio at the Radiological Society of North America (RSNA) annual meeting (November 28 – December 2, Chicago, USA). The new CT 5100 – Incisive – features CT Smart Workflow [1], a comprehensive suite of artificial intelligence* (AI) enabled capabilities designed to accelerate CT workflows, enhance diagnostic confidence, and maximize equipment up-time, helping imaging services to enhance patient outcomes, improve department efficiency, reduce operational costs, and meet ambitious financial objectives.

CT 5100 – Incisive – with CT Smart Workflow [1] includes Philips’ Tube for Life guarantee, which over the lifetime of the scanner can potentially lower operating expenses by an estimated USD 420,000 [2][3]. This newest CT innovation from Philips also provides access to Philips’ Technology Maximizer program, which provides users with the latest software and  hardware updates as they are released.

“With the combination of CT 5100 – Incisive – and CT Smart Workflow, we have embedded AI into the tools that radiology departments use every day so they can apply their expertise to the patient, rather than unnecessary distractions associated with the CT imaging itself,” said Frans Venker, General Manager of Computed Tomography at Philips. “By automating many of the process-related obstacles to CT imaging performance, we aim to clear the way for precision in dose, speed, and image quality that will help imaging departments to meet their financial, clinical, and operational goals.”

Improving the CT experience with smart clinical decision-making CT 5100 – Incisive – with CT Smart Workflow adds to Philips’ growing suite of AI-enabled smart workflow solutions, including the recently launched MR 5300 1.5T system and the new MR 7700 [4] 3.0T system. These recent smart systems introductions are all designed to support efficiency improvement, operator consistency, and diagnostic confidence at the point of image acquisition by automating many of the time- consuming procedural tasks that radiologists, technicians and staff traditionally had to perform manually.

CT Smart Workflow is the latest in a continuous program of performance enhancements for Philips’ market-leading Incisive CT platform, which includes a newly-designed patient table to accommodate bariatric patients; OnPlan gantry controls that demonstrate a 19% [5] reduction in time to results; and the company’s process improvement services Enterprise Performance Analytics – PerformanceBridge. The CT 5100 – Incisive – with CT Smart Workflow demonstrates how integrated, AI-driven solutions connect clinical intelligence and operational data across the radiology enterprise to advance precision diagnosis and treatment.

Philips’ latest innovations in CT imaging will debut at this year’s Radiological Society of North America (RSNA) Annual Meeting (November 28 – December 2, 2021, Chicago, U.S.). Join Philips at RSNA 2021 where the company will spotlight its new advanced technology driving connected workflows and smart diagnostic systems, including the CT 5100 – Incisive – with CT Smart Workflow, to increase efficiency and diagnostic confidence in precision care, and follow @PhilipsLiveFrom for updates throughout RSNA.

[1] CT Smart Workflow pending 510(k). Not for sale in the USA
[2] Life of the product is defined by Philips as 10 years. Tube for Life guarantee availability varies by country. Please contact your local Philips sales representative for details
[3] Actual operating costs for customers vary significantly because many variables exist (such as CT make and model, hospital/ imaging center size, case mix, system usage). The potential savings identified estimates the avoidance of purchasing replacement tubes over a 10-year useful life of a CT system, based on an average selling price of $140,000 per replacement tube and estimated tube life of 3 years. There can be no guarantee that all customers will achieve this result. Tube for Life guarantee availability varies by country
[4] Pending 510(k) clearance. Not available for sale in the USA
[5] Based on a study Performed at Oz Radiology Group, Queensland, Australia. Results from case studies are not predictive of results in other cases.  Results in other cases may vary
*According to the definition of AI from the EU High-Level Expert Group

For further information, please contact:

Kathy O’Reilly
Philips Global Press Office
Tel: +1 978 221 8919
E-mail: kathy.oreilly@philips.com

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and well-being, and enabling better outcomes across the health continuum – from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2020 sales of EUR 17.3 billion and employs approximately 78,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

Attachments

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.